Demand for a medicare prescription drug benefit: Exploring consumer preferences under a managed competition framework

Inquiry

Volumn 40, Issue 2, 2003, Pages 169-183

  Cline, Richard R ^a   Mott, David A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONSUMER; DRUG COST; DRUG MARKETING; ELDERLY CARE; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; UNITED STATES;

EID: 0042423394     PISSN: 00469580     EISSN: None     Source Type: Journal    
DOI: 10.5034/inquiryjrnl_40.2.169     Document Type: Article

References (44)

1. Akerlof, G.A. 1970. The Market for "Lemons": Quality Uncertainty and the Market Mechanism. Quarterly Journal of Economics 84 (3): 488-500.
2. Barringer M.W., and O.S. Mitchell. 1994. Workers' Preferences Among Company-Provided Health Insurance Plans. Industrial and Labor Relations Review 48 (1): 141-152.
3. Ben-Akiva, M., and S.R. Lerman. 1985. Discrete Choice Analysis: Theory and Application to Travel Demand. Cambridge, Mass.: MIT Press.
4. Berk, M.L., C.L. Schur, and P. Mohr. 1990. Using Survey Data to Estimate Prescription Drug Costs. Health Affairs (Fall): 146-156.
5. Berki, S.E., and M. Ashcraft. 1980. HMO Enrollment: Who Joins What and Why: A Review of the Literature. Milbank Memorial Fund Quarterly 58 (4): 588-632.
6. Bernstein, A.B., and A.K. Gauthier. 1999. Choices in Health Care: What are They and What are They Worth? Medical Care Research and Review 56 (Supplement 1): 5-23.
7. Congressional Budget Office (CBO). 2001. Medicare Reform: Providing Prescription Drug Coverage for Seniors. Statement of Dan L. Crippen. Accessed May 15, 2002 at www.cbo.gov/MoreRecentlyReleased.cfm.
8. Cubanski, J., and J. Kline. 2002. A Medicare Prescription Drug Benefit: Focusing on Coverage and Cost. Issue Brief #538. New York: The Commonwealth Fund.
9. Danzon, P.M. 2000. Pharmaceutical Benefit Management: An Alternative Approach. Health Affairs 19 (2): 24-25.
10. Davis, M., J. Poisal, G. Chulis, and C. Zarabozo. 1999. Prescription Drug Coverage, Utilization, and Spending Among Medicare Beneficiaries. Health Affairs 18 (1): 231-243.
11. nd edition. New York: John Wiley & Sons.
12. Enthoven, A.C. 1993. The History and Principles of Managed Competition. Health Affairs 12 (Supplement): 24-48.
13. Families USA. 2000. Cost Overdose: Growth in Drug Spending for the Elderly 1992-2000. Washington, D.C.: Families USA.
14. Feldman, R., and B. Dowd. 1991. Must Adverse Selection Cause Premium Spirals? Journal of Health Economics (10): 349-357.
15. Ganther, J.M., J.B. Wiederholt, and D.H. Kreling. 2001. Measuring Patients' Medical Care Preferences: Care Seeking Versus Self-Treating. Medical Decision Making 21 (2): 133-140.
16. Gates, R., C. McDaniel, and K. Braunsberger. 2000. Modeling Consumer Health Plan Choice Behavior to Improve Customer Value and Health Plan Market Share. Journal of Business Research 48: 247-257.
17. Government Accounting Office (GAO). 2000. Prescription Drugs: Adapting Private Sector Management Methods for a Medicare Benefit. GAO/T-HEHS 00-112. Washington, D.C.: GAO.
18. Grabowski, H., and C.D. Mullins. 1997. Pharmacy Benefit Management: Cost-Effectiveness Analysis and Drug Formulary Decisions. Social Science and Medicine 45 (4): 535-544.
19. Grotzinger, K.M., B.C. Stuart, and F. Ahem. 1994. Assessment and Control of Non-response Bias in a Survey of Medicine Use by the Elderly. Medical Care 32 (10): 989-1003.
20. Harrington, S.E., and G.R. Niehaus. 1999. Risk Management and Insurance. Boston, Mass.: Irwin-McGraw Hill.
21. Health Policy Alternatives, Inc. 2001. Prescription Drug Coverage for Medicare Beneficiaries: Sideby-Side Comparison of Selected Proposals as of August 2001. Washington, D.C.: Henry J. Kaiser Family Foundation.
22. Hershey, J.C., H. Kunreuther, J.S. Schwartz, and S.V. Williams. 1984. Health Insurance Under Competition: Would People Choose What is Expected? Inquiry 21 (4): 349-360.
23. Huskamp, H. A., M.B. Rosenthal, R.G. Frank, and J.P. Newhouse. 2000. The Medicare Prescription Drug Benefit: How Will the Game be Played? Health Affairs 19 (2): 8-23.
24. Iglehart, J.K. 2001. Medicare and Prescription Drugs. New England Journal of Medicine 344 (13): 1010-1014.
25. Kaiser Family Foundation. 2001. Medicare and Prescription Drugs Fact Sheet. Washington, D.C.: Henry J. Kaiser Family Foundation.
26. Laschober, M.A., M. Kitchman, P. Neuman, and A.A. Strabic. 2002. Trends in Supplemental Insurance and Prescription Drug Coverage, 1996-1999. Health Affairs 21 (February 27). Available at: www.healthaffairs.org/WebExclusives/ Laschober_Web_Excl_022702.htm
27. Lipton, H.L., D.H. Kreling, T. Collins, and K.C. Hertz. 1999. Pharmacy Benefit Management Companies: Dimensions of Performance. Annual Review of Public Health 20: 361-401.
28. Macek, M.D., R.J. Manski, C.M. Vargas, and J.F. Moeller. 2002. Comparing Oral Health Care Utilization Estimates in the United States Across Three Nationally Representative Surveys. Health Services Research. 37: 499-521.
29. Marquis, M.S., and S.H. Long. 1999. Trends in Managed Care and Managed Competition, 1993-1997. Health Affairs 18 (6): 75-88.
30. McClellan, M., I.D. Spatz, and S. Carney. 2000. Designing a Medicare Prescription Drug Benefit: Issues, Obstacles, and Opportunities. Health Affairs 19 (2): 26-41.
31. Motheral, B.R., and R. Henderson. 1999/2000. The Effect of a Closed Formulary on Prescription Drug Use and Costs. Inquiry 36 (4): 481-491.
32. Pharmacy Benefit Management Institute. 2001. Takeda and Lilly Prescription Drug Benefit Cost and Plan Design Survey Report. Tempe, Ariz.: PBMI, Inc.
33. Poisal, J. A., L. A. Murray, G. S. Chulis, and B. S. Cooper. 1999. Prescription Drug Coverage and Spending for Medicare Beneficiaries. Health Care Financing Review 20 (3): 15-27.
34. Royalty, A.B., and N. Solomon. 1999. Health Plan Choice: Price Elasticities in a Managed Competition Setting. Journal of Human Resources 34 (1): 1-41.
35. Scanlon, D.P., M. Chernew, and J.R. Lave. 1997. Consumer Health Plan Choice: Current Knowledge and Future Directions. Annual Review of Public Health 18: 507-528.
36. Stuart, B., and J. Grana. 1998. Ability to Pay and the Decision to Medicate. Medical Care 36: 202-211.
37. Stuart, B., D. Shea, and B. Briesacher. 2001. Dynamics in Drug Coverage of Medicare Beneficiaries: Finders, Losers, Switchers. Health Affairs 20 (2): 86-99.
38. Taguchi, G. 1988. System of Experimental Design. White Plains, N.Y.: Kraus International.
39. Tilly, J., and J.M. Wiener. 2001. State Pharmaceutical Assistance Programs for Older and Disabled Americans. Health Affairs 20 (3): 223-232.
40. Tourangeau, R., L.J. Rips, and K. Rasinski. 2000. The Psychology of Survey Response. New York: Cambridge University Press.
41. Wooldridge, J.M. 2002. Econometric Analysis of Cross Section and Panel Data. Cambridge, Mass.: MIT Press.
42. Worley, M.M., and J.C. Schommer. 1999. Pharmacist-Patient Relationships: Factors Influencing Quality and Commitment. Journal of Social and Administrative Pharmacy 16 (3/4): 157-173.
43. Yegian, J.M., T.C. Buchmueller, M.D. Smith, and A.F. Monroe. 2000. The Health Insurance Plan of California: The First Five Years. Health Affairs 19 (5): 158-165.
44. Zarabozo, C. 1999. Explosion in the Medicine Chest. Health Care Financing Review 20 (3): 1-13.